Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 20;21(9):4270-4292.
doi: 10.7150/ijbs.113193. eCollection 2025.

Deubiquitylating Enzymes in Hepatocellular Carcinoma

Affiliations
Review

Deubiquitylating Enzymes in Hepatocellular Carcinoma

Xingyu Mi et al. Int J Biol Sci. .

Abstract

Ubiquitination is a reversible and dynamic process, precisely regulated by ubiquitin-activating enzymes (E1), ubiquitin-conjugating enzymes (E2), ubiquitin ligases (E3), and deubiquitinating enzymes (DUBs). Dysregulation of DUBs disrupts the dynamic balance of ubiquitination, contributing to the development of various diseases, particularly cancer. An increasing number of studies have identified dysregulation of DUBs in various tumor types and have explored their regulatory mechanisms in these contexts. Hepatocellular carcinoma (HCC), the most common form of liver cancer, is highly malignant and has limited treatment options, necessitating the exploration of additional therapeutic strategies. Current research has identified dysregulation of DUBs in HCC, but their mechanisms of action remain poorly understood. Given the large number of DUB family members, there is significant potential for further investigation. This review summarizes the DUBs associated with HCC, including their structures, functions, and the mechanisms through which they regulate HCC development. Furthermore, we provide a brief overview of the discussed DUBs, aiming to offer new perspectives for future HCC research.

Keywords: deubiquitylating enzymes; hepatocellular carcinoma.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

Figures

Figure 1
Figure 1
Structural representations of DUB catalytic domains across six families. Active site cysteine (for OTUs, USPs, UCHs, MJDs, MINDYs) or zinc (for JAMMs) is highlighted. Representative structures are shown for:(A) USP family (USP7, PDB: 1NB8) (B) OTU family (OTUB1, PDB: 2ZFY) (C) UCH family (UCH-L3, PDB: 1UCH) (D) MJD family (Ataxin-3, PDB: 1YZB) (E) MINDY family (MINDY1, PDB: 5JKN) (F) JAMM family (STAMBPL1, PDB: 2ZNR).
Figure 2
Figure 2
The pathways regulated by deubiquitinating enzymes (DUBs) in the progression of hepatocellular carcinoma (HCC). The figure illustrates the pathways by which DUBs regulate glycolysis, lipid metabolism, ferroptosis, PDL1 synthesis, and multiple signaling pathways in HCC. Arrows (→) indicate promotion or activation, while blocked lines (┫) denote inhibition or suppression. Created in https://BioRender.com.

Similar articles

References

    1. Cockram PE, Kist M, Prakash S, Chen SH, Wertz IE, Vucic D. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ. 2021;28:591–605. - PMC - PubMed
    1. Sharma B, Bhatt TK. Genome-wide identification and expression analysis of E2 ubiquitin-conjugating enzymes in tomato. Sci Rep. 2017;7:8613. - PMC - PubMed
    1. Buetow L, Huang DT. Structural insights into the catalysis and regulation of E3 ubiquitin ligases. Nat Rev Mol Cell Biol. 2016;17:626–42. - PMC - PubMed
    1. Zheng N, Shabek N. Ubiquitin Ligases: Structure, Function, and Regulation. Annu Rev Biochem. 2017;86:129–57. - PubMed
    1. Komander D, Clague MJ, Urbé S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol. 2009;10:550–63. - PubMed

MeSH terms

Substances